Effectiveness of Psychotropic Medications in Children with Prenatal Alcohol and Drug Exposures: A Case Series and Model of Care.
Gaby J RitfeldJulie A KableJennifer E HoltonClaire D ColesPublished in: Child psychiatry and human development (2022)
Fetal Alcohol Spectrum Disorders affect up to 5% of the population, with additional children affected by prenatal drug exposures. The majority of these children display symptoms of ADHD and poor emotional dysregulation, a common reason for seeking psychiatric care. However, high prevalence of comorbid look-alike symptoms and limited availability of evidence-based treatments complicates psychiatric decision making in this population. The goal of the current study is to report on the effectiveness of psychotropic medications in a case series of 16 individuals with prenatal alcohol/drug exposure and propose a model for psychiatric care for this population. In addition to traditional subjective reports, an objective continuous performance test (T.O.V.A.®) was used to aid with guiding treatment. We found that T.O.V.A.®-scores improved on average from - 6.5 to - 2.9 with our psychiatric approach (p = 0.03). T.O.V.A.®-measurements were helpful in differentiating ADHD symptoms from comorbid symptoms and to guide decision-making on starting and changing medications.
Keyphrases
- mental health
- healthcare
- palliative care
- young adults
- pregnant women
- attention deficit hyperactivity disorder
- sleep quality
- quality improvement
- decision making
- randomized controlled trial
- autism spectrum disorder
- adverse drug
- systematic review
- working memory
- alcohol consumption
- pain management
- affordable care act
- depressive symptoms
- electronic health record